The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. 1997.
D005260:Female; D049673:History, 20th Century; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000266:history* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000209:etiology / Q000266:history*; D009902:Optic Neuritis / Q000150:complications / Q000188:drug therapy / Q000266:history*; D011241:Prednisone / Q000266:history* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000266:history; D012306:Risk
D011241:Prednisone; D008775:Methylprednisolone